PAM
PACB icon

Panagora Asset Management’s Pacific Biosciences PACB Stock Holding History

Panagora Asset Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-502,663
Closed -$664K – 1263
2026
Q1 		$664K Buy
+502,663
New +$899K ﹤0.01% 796
2023
Q1 		– Sell
-74,395
Closed -$609K – 1513
2022
Q4 		$609K Buy
74,395
+2,048
+3% +$17.6K ﹤0.01% 1081
2022
Q3 		$420K Buy
+72,347
New +$415K ﹤0.01% 1191
2022
Q2 		– Sell
-31,351
Closed -$285K – 1567
2022
Q1 		$285K Sell
31,351
-14,612
-32% -$168K ﹤0.01% 1365
2021
Q4 		$940K Sell
45,963
-17,261
-27% -$417K 0.01% 953
2021
Q3 		$1.61M Sell
63,224
-42,588
-40% -$1.26M 0.01% 767
2021
Q2 		$3.7M Sell
105,812
-47,071
-31% -$1.37M 0.02% 515
2021
Q1 		$5.09M Buy
152,883
+61,214
+67% +$2.14M 0.03% 460
2020
Q4 		$2.38M Buy
+91,669
New +$1.56M 0.01% 641
2020
Q3 		– Sell
-17,056
Closed -$59K – 2740
2020
Q2 		$59K Hold
17,056
– – ﹤0.01% 1936
2020
Q1 		$52K Hold
17,056
– – ﹤0.01% 1877
2019
Q4 		$88K Sell
17,056
-15,171
-47% -$77.1K ﹤0.01% 1827
2019
Q3 		$166K Sell
32,227
-177,983
-85% -$995K ﹤0.01% 1683
2019
Q2 		$1.27M Sell
210,210
-3,590
-2% -$25.2K 0.01% 1027
2019
Q1 		$1.55M Sell
213,800
-98,308
-31% -$711K 0.01% 937
2018
Q4 		$2.31M Sell
312,108
-138,220
-31% -$876K 0.01% 729
2018
Q3 		$2.44M Buy
+450,328
New +$1.93M 0.01% 770
2017
Q4 		– Sell
-174,634
Closed -$917K – 2342
2017
Q3 		$917K Sell
174,634
-402,084
-70% -$1.73M ﹤0.01% 1152
2017
Q2 		$2.05M Buy
576,718
+19,625
+4% +$79.1K 0.01% 847
2017
Q1 		$2.88M Sell
557,093
-6,533
-1% -$32K 0.01% 747
2016
Q4 		$2.14M Buy
563,626
+5,220
+0.9% +$37.9K 0.01% 876
2016
Q3 		$5M Sell
558,406
-118,495
-18% -$990K 0.02% 551
2016
Q2 		$4.76M Buy
676,901
+41,893
+7% +$383K 0.02% 573
2016
Q1 		$5.4M Sell
635,008
-137,851
-18% -$1.36M 0.03% 554
2015
Q4 		$10.1M Buy
772,859
+196,757
+34% +$1.77M 0.05% 346
2015
Q3 		$2.11M Buy
576,102
+47,065
+9% +$230K 0.01% 749
2015
Q2 		$3.05M Sell
529,037
-1,822
-0.3% -$10.5K 0.02% 661
2015
Q1 		$3.1M Buy
530,859
+106,081
+25% +$731K 0.02% 645
2014
Q4 		$3.33M Buy
424,778
+8,938
+2% +$57.2K 0.02% 586
2014
Q3 		$2.04M Sell
415,840
-16,064
-4% -$84K 0.01% 741
2014
Q2 		$2.67M Sell
431,904
-15,773
-4% -$78.9K 0.01% 718
2014
Q1 		$2.4M Sell
447,677
-105,806
-19% -$669K 0.01% 808
2013
Q4 		$2.9M Buy
553,483
+16,272
+3% +$74.7K 0.01% 710
2013
Q3 		$2.97M Sell
537,211
-61,761
-10% -$214K 0.01% 678
2013
Q2 		$1.51M Buy
+598,972
New +$1.49M 0.01% 891

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Panagora Asset Management's PACB Position: Q2 2026 in Review

Panagora Asset Management sold out of Pacific Biosciences (PACB) in Q2 2026, closing a stake of 502,663 shares — an estimated $664K sold.

Panagora Asset Management first reported a position in PACB in Q2 2013 and held it in 35 quarters. The position peaked at $10.1M in Q4 2015. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Panagora Asset Management reported no remaining Pacific Biosciences position as of Q2 2026 after selling out during the quarter.
  • Panagora Asset Management sold 502,663 Pacific Biosciences shares in Q2 2026, an estimated $664K.
  • Panagora Asset Management first reported a position in Pacific Biosciences in Q2 2013 and held it in 35 quarters.
  • Panagora Asset Management's Pacific Biosciences position peaked at $10.1M in Q4 2015.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.